Moderna's 'surprise' IP court order could set up a big settlement for Roivant, Arbutus — analysts
The battle over who owns the patented lipid nanoparticle technology that carried the Covid-19 vaccines across the finish line and into millions of people’s arms …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
